Alternate-Day Buprenorphine Administration. Phase VI - 7 - Contacts and Locations

Home

Alternate-Day Buprenorphine Administration. Phase VI - 7

This study has been completed.

Study NCT00000225. Last updated on June 23, 2005. Information provided by National Institute on Drug Abuse (NIDA)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00000225

Locations


United States, Vermont
	Treatment Research Center
	Burlington, Vermont, United States, 05401

Sponsors and Collaborators

National Institute on Drug Abuse (NIDA)

University of Vermont

Investigators


Principal Investigator:	Warren Bickel, Ph.D.	University of Vermont